Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19

NCT04649775 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT04649775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04649775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Terminated
Start date
April 9, 2021
Completion date
November 8, 2021
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid19, hypoxia, respiratory rate